Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3355 |
|
| Actual shortage: | 217 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
61 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-08-23 | 2023-09-01 | 202830 |
| APO-ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-04-19 | 2024-06-28 | 225779 |
| APO-ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-11-07 | 2018-01-18 | 28534 |
| APO-ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-12 | 2024-03-22 | 215973 |
| APO-ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-07-29 | 2020-08-07 | 121322 |
| APO-ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-11-06 | 2023-12-15 | 209372 |
| APO-ALLOPURINOL | 100MG | TABLET | Resolved | 2024-03-27 | 2024-04-05 | 223561 |
| APO-ALLOPURINOL | 300MG | TABLET | Resolved | 2019-01-30 | 2019-02-13 | 74014 |
| APO-ALLOPURINOL | 300MG | TABLET | Resolved | 2024-05-31 | 2024-09-27 | 229389 |
| APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2023-03-30 | 2023-05-26 | 188424 |
| APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2020-08-19 | 2021-05-17 | 122465 |
| APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2023-11-06 | 2024-01-26 | 209369 |
| APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2020-08-19 | 2021-05-17 | 122468 |
| APO-ALLOPURINOL | 300MG | TABLET | Resolved | 2024-03-15 | 2024-04-05 | 222458 |
| APO-ALLOPURINOL | 100MG | TABLET | Resolved | 2020-10-28 | 2021-05-10 | 127328 |
| APO-ALLOPURINOL | 100MG | TABLET | Resolved | 2020-02-13 | 2020-04-23 | 105988 |
| APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2023-12-15 | 2024-01-26 | 213584 |
| APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2024-06-13 | 2024-09-27 | 230466 |
| APO-ALLOPURINOL | 100MG | TABLET | Resolved | 2024-07-25 | 2024-09-27 | 233697 |
| APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2023-02-16 | 2023-05-26 | 185028 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |